2023 IBCN Meeting
September 28 – 30
2023 International Bladder Cancer Network Annual Meeting
Dear Friends & Colleagues,
The meeting of the International Bladder Cancer Network, on September 28th – 30th in Montreal, Canada is coming close. We are grateful to our local host Wes Kassouf (McGill University) for welcoming us and having made arrangements of an attractive hotel and venue.
As usual, we will start with an informal evening reception on Thursday Sept 28th in the meeting hotel. The meeting will be held all day on Friday Sept 29th and until late afternoon of Saturday Sept 30th (end at around 4 pm).
The meeting will be held at Hyatt Centric Montreal. This hotel is close to the charming Parisian-style quarter of Old Montreal and sits on the crossroads of old and new.
We will have our trademark ‘IBCN Dinner’ on Friday evening in the restaurant Mechant Boeuf. This is a modern steakhouse in Old Montreal that is known for its French brasserie menu, warm décor, and lively ambiance.
A block of rooms will be made available to IBCN meeting attendees at Hyatt Centric Montreal. Please use the following link (https://www.hyatt.com/en-US/group-booking/YULCT/G-MCGI) to obtain a discounted rate on a first-come, first-serve basis as long as rooms last. Remember that all members are responsible to cover the cost of their own hotel room this year. Trainees who are already IBCN members and who submitted an abstract to this year’s meeting may apply by simple e-mail to have two nights of accommodation covered by the IBCN. In this e-mail please include your current position, current supervisor, year of becoming IBCN member, and title of submitted abstract.
Please remember: The meeting is only open to members. If you have not registered yourself as a member and paid your dues (possible now by PayPal on IBCN webpage), please contact us.
Last but not least, we are delighted to announce an exciting scientific program that includes:
- Keynote speaker Andrew Hsieh (Fred Hutch Cancer Center, Seattle), will focus on epigenetics, transcriptional reprogramming.
- Keynote speaker Michael Shen (Columbia University, NY) and a following panel discussion will focus on organoids in translational research and clinical impact.
- IBCN speaker Seth Lerner (Baylor College of Medicine, Houston) speaking on “TCGA and beyond”.
In addition, more than 70 submitted abstracts will be presented as oral or poster presentations. Abstract presenters should check the website for abstract assignments, and additional instructions will be posted on the IBCN website.
Looking forward to seeing you again!